Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus (HCV)”

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT01849588
What this trial is testing

HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Cancer
Massachusetts General Hospital 3
Testing effectiveness (Phase 2)Study completedNCT02716779
What this trial is testing

Influence of Ribavirin on the Initial Virological Response in Treatment Naïve Patients With Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 68
Large-scale testing (Phase 3)Study completedNCT01497834
What this trial is testing

Study in Combination With BMS-790052 and BMS-650032 in Japanese Hepatitis C Virus (HCV) Patients

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 224
Large-scale testing (Phase 3)Ended earlyNCT00686881
What this trial is testing

Efficacy of Peginterferon Alfa-2b (SCH 054031) vs Glycyrrhizin in Interferon (IFN)-Treated Patients With Chronic Hepatitis C and F2/F3 Liver Fibrosis (P04773)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 261
Testing effectiveness (Phase 2)Study completedNCT00590564
What this trial is testing

SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study

Who this might be right for
Hepatitis C
Memorial Sloan Kettering Cancer Center 42
Testing effectiveness (Phase 2)Study completedNCT00487318
What this trial is testing

Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin

Who this might be right for
Chronic Hepatitis C
Bader, Ted, M.D. 40
Large-scale testing (Phase 3)UnknownNCT00437476
What this trial is testing

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

Who this might be right for
HIV InfectionsHepatitis C
IRCCS San Raffaele 60
Post-approval studies (Phase 4)Study completedNCT03063879
What this trial is testing

Treating Hepatitis C in CRF Using Sofosbuvir and Daclatasvir

Who this might be right for
Hepatitis C, ChronicChronic Renal Failure
Tehran University of Medical Sciences 95
Testing effectiveness (Phase 2)Study completedNCT01909804
What this trial is testing

Safety and Efficacy of Sofosbuvir Plus Velpatasvir With or Without Ribavirin in Treatment-experienced Subjects With Chronic HCV Infection

Who this might be right for
Hepatitis C
Gilead Sciences 323
Not applicableStudy completedNCT03197155
What this trial is testing

Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence

Who this might be right for
Hepatocellular CarcinomaHepatitis CDirect Acting Antivirals
Hospices Civils de Lyon 68
Large-scale testing (Phase 3)Study completedNCT01023035
What this trial is testing

Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM2)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 687
Large-scale testing (Phase 3)Ended earlyNCT01821625
What this trial is testing

Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C

Who this might be right for
ThrombocytopeniaHepatitis C
University of Texas Southwestern Medical Center 7
Early research (Phase 1)Study completedNCT02116543
What this trial is testing

TD-6450 MAD Study in HCV Infected Subjects

Who this might be right for
Hepatitis CHCV
Theravance Biopharma 47
Testing effectiveness (Phase 2)Ended earlyNCT02971033
What this trial is testing

Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
VA Office of Research and Development 2
Large-scale testing (Phase 3)WithdrawnNCT01797848
What this trial is testing

Efficacy and Safety Evaluation of a Treatment Consisting of Peg Interferon Alfa + Ribavirin + Daclatasvir in HCV Genotype 1 and 4 Treatment naïve Patients

Who this might be right for
Hepatitis C
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT03811678
What this trial is testing

The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects

Who this might be right for
Chronic Hepatitis c
Sunshine Lake Pharma Co., Ltd. 120
Early research (Phase 1)Study completedNCT01928147
What this trial is testing

A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients

Who this might be right for
Hepatitis C, Chronic
Presidio Pharmaceuticals, Inc. 114
Large-scale testing (Phase 3)UnknownNCT03343444
What this trial is testing

Safety & Efficacy of Sofosbuvir 400mg/Ledipasvir 90mg in the Treatment of Chronic Hepatitis C Adolescents

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy of
Egyptian Liver Hospital 80
Post-approval studies (Phase 4)Ended earlyNCT00803309
What this trial is testing

Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients

Who this might be right for
Hepatitis C, Chronic
HepNet Study House, German Liverfoundation 99
Not applicableActive Not RecruitingNCT02995252
What this trial is testing

The HOPE Study: Characterizing Patients With Hepatitis B and C

Who this might be right for
Hepatitis B， ChronicHepatitis C
University of Maryland, Baltimore 550
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation